All In Biotech

Drug Trial Radar · NCT07197645

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

A Phase 1 Pharmacokinetic, Dosimetry, Safety, and Dose Optimization Study for a Single Dose of TLX090-Tx (153SmDOTMP) to Treat Metastatic Bone Pain

Last checked: Nov 20, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

33

Planned (sponsor's estimate)

Start

Oct 21, 2025

Primary completion

Apr 26, 2027

Study completion Jul 5, 2027

Sponsor

Sponsor type
Industry
First posted
Sep 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in patients with painful bone metastases.

Conditions

  • Bone Pain
  • Metastatic Bone Tumor
  • Bone Metastases in Subjects With Advanced Cancer

Interventions

  • 153Sm-DOTMPDrug

    TLX090-Tx will be administered as a single ascending intravenous dose to participants with at least 1 confirmed painful osteoblastic bone tumor that exhibits avid uptake as shown by 99mTcdiphosphonate bone scans undertaken within 60 days of dosing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and severity of treatment-emergent adverse events (TEAEs) [Safety and Tolerability]Time frame: Up to 6 weeks post-dose

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Biogenix Molecular, LLC, CIRA Health

    Miami, Florida · Recruiting

  • NovaCure

    Miami, Florida · Recruiting

  • Houston Metro Urology

    Houston, Texas · Recruiting

  • Oncology Consultants

    Houston, Texas · Recruiting

  • Excel Diagnostics and Nuclear Oncology Center

    Houston, Texas · Recruiting

  • University of Texas Medical Branch at Galveston (UTMB)

    Houston, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.